Production (Stage)
Rani Therapeutics Holdings, Inc.
RANI
$0.5289
-$0.031-5.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.80M | -30.02M | -28.17M | -30.58M | -33.08M |
| Total Depreciation and Amortization | 1.03M | 1.03M | 989.00K | 948.00K | 882.00K |
| Total Amortization of Deferred Charges | 232.00K | 232.00K | 232.00K | 232.00K | 232.00K |
| Total Other Non-Cash Items | -4.03M | -6.19M | -9.97M | -13.20M | -15.08M |
| Change in Net Operating Assets | -1.68M | -544.00K | -2.40M | -2.61M | -1.43M |
| Cash from Operations | -34.24M | -35.50M | -39.32M | -45.21M | -48.48M |
| Capital Expenditure | -301.00K | -268.00K | -404.00K | -758.00K | -999.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 28.05M | 20.08M | 30.97M | 42.53M | 37.03M |
| Cash from Investing | 27.74M | 19.81M | 30.56M | 41.77M | 36.03M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.75M | -5.00M | -1.25M | -- | -- |
| Issuance of Common Stock | 18.55M | 18.63M | 9.35M | 460.00K | 384.00K |
| Repurchase of Common Stock | -70.00K | -47.00K | -38.00K | -53.00K | -38.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.73M | 13.59M | 8.06M | 407.00K | 346.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.23M | -2.10M | -695.00K | -3.04M | -12.11M |